Objective To determine whether the use of inhaled corticosteroids during pregnancy increases
the risk of pregnancy induced hypertension and pre-eclampsia among asthmatic women. …

In this guideline update, we highlight important and new findings related to pharmacological
therapy of chronic obstructive pulmonary disease (COPD) that should change clinical …

BACKGROUND: Although reassuring data exist on the use of low-to-moderate doses of inhaled
corticosteroids (ICSs) during pregnancy, there are inadequate data for women receiving …

Background: The use of administrative databases to perform epidemiological studies in
asthma has increased in recent years. The absence of clinical parameters to measure the level …

Extensive literature exists on potential risk factors for childhood asthma. To the authors’
knowledge, no investigators have yet attempted to disentangle the effects of those determinants …

Background Although it is a key-recommendation of all recent asthma guidelines, self-management
education is still insufficiently offered in primary care settings. Aims of the study To …

Background: Thirteen studies investigating the association between asthma during pregnancy
and perinatal mortality reported generally no increased risk. Most of these studies should …

Aim: To investigate whether the maternal use of different doses of inhaled corticosteroids (ICSs)
during the first trimester of pregnancy for the treatment of asthma increases the risk of …

Background We previously reported an increased prevalence of any congenital malformation
among women experiencing moderate-to-severe asthma exacerbations during the first …

RATIONALE: Since the last published Canadian Thoracic Society (CTS) COPD guideline in
2007 and the 2008 update–highlights for primary care, many new clinical trials have …